INTS
Intensity Therapeutics, Inc. Common stock
Mentions (24Hr)
0.00% Today
Reddit Posts
INTS. Hit $10.65 today Called this 2 days ago at under $8. People shit on me
Mentions
Investors saving for retirement need ETFs and bonds, but with good DD, appropriately-sized positions, taking some profit on the way up, and sticking to exit plans I haven't had a bad time stock-picking; using small scalps (<10%) to buy more of whatever's in the green compounds very quickly. I usually cut off bags just as quickly, though there have been exceptions (WWR), and almost never average down except for an overcorrection (e.g. the INTS split). Most losses have been from not knowing when to sell a short-term play.
Oh yeah. many buying at +100%. Just look at the posts from the past 30 minutes. Just like INTS: another crop of newbies thinking they are investing in the "cure for cancer".
Sigh. No, its not an approval. AIM inserted the word "approval" into the headline to lead people to think it is an approval to market the drug. It is a patent being granted, not an approval to market the drug. This is going to be another INTS. Lots of bagholders at over $1 being created right now as we watch.
The news is a nothing burger. Doesn't mean the stock won't run more today. Personally, I'm not touching it at these levels. It is a good reminder of the power of the "cure for cancer" regards to move a stock. Remember INTS (to choose just one recent example). AIM will be under a buck again by end of next week
# INTS. News: [https://ir.intensitytherapeutics.com/news-events/press-releases/detail/121/intensity-therapeutics-inc-provides-update-on-the-phase-2](https://ir.intensitytherapeutics.com/news-events/press-releases/detail/121/intensity-therapeutics-inc-provides-update-on-the-phase-2)
Always exceptions of course, but most of time its not a good idea to buy something that is up 150% in less a day. That goes triple for pennies. Its amazing how quickly management of a penny stock company can put out an offering to take advantage of a price spike. How many of us got burned when ATON and INTS did this? (to name just one recent example)
It's nice, but it's approximately half what I could have gained if I'd held initial NUAI (got in at 0.33), not ignored DFLI (saw it at 0.43), and not sold INTS (had thousands of shares at 0.25). Shorting tech is an easy play for the next month at least, just make sure any calls you sell are covered and don't play on bounce days (e.g. the Iran war suddenly ending - stocks will rally even if macros remain poor).
\-7.3% down this month, 22% up YTD, and 78% up since last June (when I first took stocks seriously). I used to take small positions in runners (e.g. IXHL, BTAI), but they were inconsistent and needed too much attention. Now I build big positions in stocks with legs (e.g. PLSR, SLS, ABOS, ASX:EOS, LSE:HUI). Had three losses. One (PLBY) was just daft; initial lateness made me hungry for bigger gains, so +20% turned into -5% (and dropping). A second (INTS) required risky dip-buying to return to profit. I took the profit percentage to buy more when it's diluted, but am determined to *never* leave that stock.
I'm considering taking half, but alternatively might use profit from other sales to buy more when the dip happens. Second-guessing INTS hasn't worked out well for me in the past. (I was one of the first talking about it but sold due to reverse-split fears shortly before it ran up 600%.)
Congrats if you are profitable after INTS dip-buying. Might want to consider locking in that profit. They are cash-poor and have already come out and said very clearly and directly that are seeking financing to be able to fund their clinical trials. Dilution is by far the most likely source of that funding and they will dilute as soon as they find someone willing to do a deal with them.
Very optimistic for RBW. Buying the INTS dip was what we call a pro-gamer move.
Weekly outlook as of right now : Watchlist Tuesday : **$OLB** **$KXIN** **$SRXH** **$SGN** **$GNS** Week ahead : **$BIVI** : ( Feb-18) : https://finviz.com/news/308857/biovie-announces-abstracts-accepted-for-presentation-at-the-2026-american-college-of-psychiatrists-annual-meeting **$AZTR** : Special meeting (Mar-6) : https://finviz.com/news/303289/azitra-announces-adjournment-of-special-meeting-and-information-for-reconvened-special-meeting **$INTS** : (RS 1-25 Feb-18) : https://finviz.com/news/310352/intensity-therapeutics-announces-reverse-stock-split
INTS seems to have found a post-split announcement floor. Given this *and* the fact the split is only a few days away, I'm buying more.
That is what I would do. That said, look at recent Reverse splits on penny stocks and you should see exactly what I described. I only know one exception on the ones I play and that is APGO but they have excellent projects, good story and marketing plan. Every other one didn't really have anything to work with, restructured because they couldn't raise money at a reasonable price so since they didn't have really anything before they couldn't hold the new price either. Almost every time it ends up being significantly cheaper in a few days and that is when I would look to re-enter if I believed in it. I will be honest though. They rarely correct the issues and just drift until they have some real catalyst. With INTS, I believe the pattern will continue. I would watch for the raise they mentioned in the their 2026 outline and look to buy back after it is announced. That said, you do you.
So now INTS pulls its reverse-split. I was in early and sold before the 600% rise, thinking it would reverse split in October; I get *back* in, and it does this? I'm sticking around: its drug is unreal. But mad is an understatement.
Alright fellas, INTS surged from .30 to 1.75 about 3 months ago on groundbreaking phase 1/2 data on their tumor treatment with direct injection. Since then they have bled all the way back down to .39 because day traders have no patience mainly. They are expected to start phase 3 enrollment this or next month. In terms of “safest” high risk/reward plays, I can’t find a better one than this one at these levels. They filed a patent for their novel treatment and have multiple studies in their pipeline. Their market cap is $20 million currently and this is a no brainer $200+ mil company that will either get joint ventures or straight up bought out most likely. Good luck out there gents. I have all my cash parked here and expecting a 5-10x in the coming months
I'm iffy about the squeeze too. These squeeze plays get talked up alot (I've talked up a few of them myself) but they usually don't happen. I'm holding my entire position (both long term and trading position) for now because the stock really isn't up that much. Its up 116% past month. When SLS ran recently it went about 250% in a month. Heck even piece of crap biotech stock INTS ran about 500% end of Oct. on absolute nothingburger news.
Most of them, especially when I was new to trading. Too many speculative biopharma, and I wasn't really looking at things like p/e ratio - just assumed they'd moon. They need capital to do what they do, and they have products with good results that I believe in, but I should have stayed away. BMEA, TOVX, RVPH, INTS, SKYE, HUMA, FEMY, RVPH.
INTS is at a good price right now, SLS is on a run for the next week or so, and everyone is hyping space.
Do you think INTS will recover?
DFLI, GPUS, INTS, to name but a few, if you want a stock to fall on its arse, lemme know and I’ll buy it
INTS is also at a good price
It'll be some tiny biotech penny stock like INTS. It could do 10x this year.
INTS if you want a complete degen gamble.
Aktx may be breaking out. News expected in January at some point. Could make a great swing for an INTS like run.
I wish T212 would stop sending me +10% notifications and getting me excited about INTS, only to check it and see it bugging out where it was earlier 😑 I need a win today after RVPH, fuck sake.
RVPH, SLS, and INTS are better picks
RVPH and INTS are my plays for the next 1-3 months. BZFD looks promising.
The ones I will provide have risk attached to them but also have potential. Not going to guarantee they are winners. My plays are RVPH, INTS, and PLBY.
RVPH, INTS, and PLBY are the only Pennie’s I can take risk on right now. None of them are guaranteed to pay out, but I’m still in the game.
Just bought a truckload of INTS after them filing their patent. Close to compliance so something is up
INTS filed a patent yesterday for cancer treatment this will pump soon
PCSA is looking like a repeat of INTS. Happy for folks showing gains this morning. Just don't get greedy; take your profits.
INTS patent grant yesterday, not a lot of volume yet. Only up 2% premarket
Thanks for sharing the infos. $INTS really seems to be interesting. Compliance extension till June 26. I just have the feeling, that they will raise cash as soon as they put out good news (cash runway Q1 27). Could be a good "buy the rumor sell the news" investment.
PM Watchlist: **$EONR** : Venezuela Trump blockade, Dips **$ASST** : CEO 500k shares purchase, **$CHR** again 🇨🇳☠️, if breaks 0.047 PM --- Some longer prospects today: **$PCSA** : Currently Halted. Dec17 : 1-25 RS, float reduced to 2.2M, 10% shorted : [https://www.sec.gov/ix?doc=/Archives/edgar/data/0001533743/000149315225027680/form8-k.htm](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001533743/000149315225027680/form8-k.htm) Why interesting? The timing: NGC- Capecitabine PH2 (Metastatic breast cancer) , expected H2 2025. Added to Watchlist Incase of a sell off at open bell and for dips. This things rarely happen in a vacuum. --- **$INTS** : update here. December 16 company filed a patent for cancer treatment. In itself patent is very bullish, but the timeframe here is important with compliance. Holding a position at 0.42 15% SL: https://preview.redd.it/b9ntghk6gp7g1.jpeg?width=1261&format=pjpg&auto=webp&s=69beb7367d553a57b10d932f4659ff65e8a132f9
I will hold INTS until at least Friday.
Will monitor INTS and PSTV for the first hour.
INTS, RVPH, PLBY, and maybe PSTV
Sheesh what happened to INTS?
PFSA the pumpers have been shaken out and its now back at 0.15. Many couldn’t stomach holding it through the weekend or used their followers (looking at you Peter penny SMH) Catalyst this weekend and if the clinical update is impressive enough then this will start moving rapidly northwards. 16 months cash runway and no reverse split on the table. This is my biggest holding right now and I’m hoping for another INTS here
Stocks I recommend but haven't mentioned much: **PYXS** (first-in-concept with a smallish, locked-up float awaiting Q4 data release) and **INO** (developer of DNA immunotherapies for HPV-linked tumours expecting imminent approval). **CELZ** is looking like a godsend, developing cell lines for diabetes and chronic back pain. Topline data is expected by May 21st 2026 but its cash runway can last until next October. A rare chance to accumulate. Stocks I recommend and have mentioned a lot: **PLSR** (poised to dominate global supply of a rare and eldritch isotope); **SLS** (producing the closest thing we have to a generalised cancer survivability drug), and **HUI** (a.k.a. **HUIPF**), pursuing green hydrogen recovery from petrochemical and construction industries in the Middle East. I also called out ASX:**EOS**, which is up 13% in five days and has plenty of room to run. You all know **INTS** already. Never do your own research. The value of your investment can go up as well as further up. 110% of retail accounts make mad racks from tips off Reddit. Sell your wife's jewellery right now. Obey the voices. Not financial advice.
PM Watchlist: **$YCBD** & **$AKAN** https://www.washingtonpost.com/business/2025/12/11/trump-marijuana-reclassification-executive-order/ Watching **$IXHL** just Incase meme pump. ___ Tomorrow plays: **$INTS** : 2 day catalyst, day 2 : Dec 11 : 5-6:30pm (10% climb). Dec 12 : 12-1:30pm https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium **$PFSA** : catalyst Dec 11-13 : https://finviz.com/news/237253/profusa-to-present-late-breaking-us-based-clinical-trial-update-at-paris-vascular-insights-2025 **$BCRX** : ORLADEYO PDUFA **Dec 12** , risky, if approved would be first of its kind.
Can't recommend PYXS or AZTR enough for Q4 2024 biotech opportunities. The real star's still SLS, but PYXS and AZTR have explosive potential. It's also a great time to be accumulating INTS and FBLG. I put FBLG on a watchlist a month ago and it's up c. 50%. Outside of biotech, HUIPF and PLSR are primed for explosive growth - conceptually and financially. I'm still in awe at how committed HUIPF's CEO appears to be. She used her own stake as collateral for a credit line rather than dilute.
PM Watchlist: **$NXDR** **$CGTL** **$SIDU** & **MNTS** **$RVPH** for dips ___ Thursday plays into weekend look for dips: **$INTS** : $INTS : 2 day catalyst Dec 11 : 5-6:30pm Dec 12 : 12-1:30pm https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium **$PFSA** : catalyst Dec 11-13 : https://finviz.com/news/237253/profusa-to-present-late-breaking-us-based-clinical-trial-update-at-paris-vascular-insights-2025
With the state of INTS financials and the fact that the INT230‑6 drug is the company's one and only shot at breaking free of the current state of affairs they find themselves in. One would immediately assume that this is a BEWARE. However, INT230‑6 has shown tumor necrosis and immune activation signals in earlier studies that suggest a BUY market should Stage 2 prove successful. Adding to this is a significant growth opportunity that is compounded on top of this, should the drug reach the actual market. What do you guys think?
INTS is the play of the decade.
Not a bot but sgbx genuinely could squeeze hard today and INTS is also a good stock!
I lost out on £20k because I sold INTS two weeks before its first pump. The fix is to wait for it to come back down (a frequent occurrence with biotech and mining) or buy something else.
In at 0.56. RVPH can't run like BTAI did because there's no exact date for the FDA meeting. Speculation aside, short-term upside and downside are about even. But the drug itself (brilaroxazine) threatens the market share of *all* current anti-psychotics. Along with GPS (SLS), INT230-6 (INTS), and leronlimab (CYDY), it's one of the most clinically promising drugs in biotech right now. There's some better stuff at the proof-of-concept stage (PYXS) or Phase 1 (LNAI) but they're essentially gambles. If you've got the risk appetite to choose biotech at all, you're okay holding RVPH for years.
Keep holding/averaging down on INTS
PFSA catalyst on the 11th. So many eyes on it now on X etc. that it will start moving today and tomorrow IMO, could be another INTS which went from the 20s to 1.50
INTS and SGBX looking hella juicy looking at the numbers and its still not had its ride yet 🔥
PM Watchlist in attachment 👇 Current plays: **$INTS**: Dec 9-13 catalyst : [https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium](https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium) **$MIST** : Dec 13 PH3 : [https://www.reddit.com/r/pennystocks/s/fw1pkuTT24](https://www.reddit.com/r/pennystocks/s/fw1pkuTT24) **$PFSA** : catalyst Dec 11-13 : [https://finviz.com/news/237253/profusa-to-present-late-breaking-us-based-clinical-trial-update-at-paris-vascular-insights-2025](https://finviz.com/news/237253/profusa-to-present-late-breaking-us-based-clinical-trial-update-at-paris-vascular-insights-2025) **$BCRX** : Dec 12 PDUFA **$RVPH** : December expected catalyst. https://preview.redd.it/pjugcx2d646g1.jpeg?width=1299&format=pjpg&auto=webp&s=a4754a2caba3fdd23bb0a8ba3abf6a07b2d796dd
**$INTS** back in at 0.49, after taking 40% profits in PM : catalyst Dec (9-12) : finviz.com/news/245334/in… Entered **$VSA** at 0.093 looking for a swing. 🇨🇳🚩☠️. Will add 2-3 more in AfterHours for swing into PreMarket. Keep an eye out
Yessir PAVS AND CETX RAN!! Now it's time for SGBX AND INTS! LFG 🔥
Premarket/Week outlook for you to DD: **$QCLS** : Martin Shkreli, trending. **$ASST** : Fidelity 11% stake : https://www.sec.gov/Archives/edgar/data/1920406/000031506625002963/xslSCHEDULE_13G_X01/primary_doc.xml **$VSIG** : Solid spin off PR, trending, low float: https://finviz.com/news/246188/vci-global-announces-spin-off-of-vccg-at-us168-million-valuation-as-part-of-dual-track-ipo-strategy **$INTS** : 180 days extension, solid pipeline, catalyst (Dec 9-12): https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium **$BCRX** : ORLADEYO PDUFA **Dec 12** , risky, if approved would be first of its kind. **$MIST** : **Dec 13** Phase 3 PDUFA : https://www.reddit.com/r/pennystocks/s/hUdF5AsiD3 **$RVPH** : No specific date but expected anytime now.
$VIVK $RUBI $EONR - Oil Setups Anticipating SPR Oil Purchase Nearing. $SLS And $INTS - Expecting Increase On News Releases $DFLI And $AIRE - Quick 5-10% Swings $MIST - Steady Increase As Nearing Catalyst $GPUS - Searching For Bottom
take the entire 300k and buy up nearly 1% of INTS and let the baby ride $30M or bust
Still shilling SLS, AZTR, INTS, and RVPH. My research on other biotechs continues.
I want to support INTS but I got burnt bad by it recently
Premarket watchlist: **$AKAN** : 20% shorted, microscopic float 0.7M , 45% in AH no news. **$DEVS** : steady climb into AH, solid news : https://www.businesswire.com/news/home/20251204166343/en/Louisiana-Community-Development-Authority-Authorizes-up-to-%24402-Million-in-Revenue-Bonds-for-Southern-Energy-Renewables-Louisiana-Fuel-Project **$INTS** : looking for Friday dip to add, catalyst (Dec 9-12) solid pipeline: https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium **$MIST** & **PRPH** : Anyday.
Nice! I have some INTS I’ll keep an eye on it. Could be ready to be coming up for a run 🏃
Premarket watchlist: **$AKAN** : 20% shorted, microscopic float 0.7M , 45% in AH no news. **$DEVS** : steady climb into AH, solid news : https://www.businesswire.com/news/home/20251204166343/en/Louisiana-Community-Development-Authority-Authorizes-up-to-%24402-Million-in-Revenue-Bonds-for-Southern-Energy-Renewables-Louisiana-Fuel-Project **$INTS** : looking for Friday dip to add, catalyst (Dec 9-12) solid pipeline: https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium **$MIST** & **PRPH** : Anyday.
INTS showing signs of life.
Hoping that Lumen Technologies and INTS can both be on the climb 🙏🙏 plssss 🤧🤧😅
INTS -popped 400% a week after loading
VOR and INTS. 1100% and 380% respectively
Keeping a lookout for RVPH. Phase III clinical trial almost completed, mid-late December could have news on FDA approval. Reminds me of SCNX and INTS.
Looks like you are 50% down on INTS also, congrats!
INTS climbing on low volume. She going vertical again soon
One of these times very soon INTS is going to go vertical and never look back. These levels are beyond a gift for what they’ve shown in their phase 2 treatment of tumors
INTS set it and forget it. 5-10 bagger
SLS and AZTR are my Q4 biotech plays. SLS has a far better product and prospects, but AZTR's float is tiny - even moderate results will send it up 200-300%. PLSR is also dropping new appraisals soon. If their helium-3 scales up with recent land purchases (i.e. +1,000%), we enter the fusion age and they become a three comma company in waiting. Next month, I plan to take big positions in HUI (Hydrogen Utopia International) and either ASX:EOS or INTS depending on the current state of INTS's cash flow. I'm still mad I sold INTS two weeks before it ran 600%. That's the last time I let reserve split fears shake me out.
Potentially just a big buy. It happened to INTS and SLS in the last few days.
TNMG just spazzed like when INTS was going up
1.5 billion volume on INTS when they released their novel tumor treatment news 2 weeks ago. Volume ever since has been like 1% of that on the daily. That’s how it was manipulated so hard. Offering was done at 80 cents, it’s going back to those levels atleast. Multi Dollar land soon after that.
A quick 7% scalp on INTS. No idea what the catalyst is. Maybe clinical trials resumed?
Didn't see a catalyst for this INTS pop. Maybe news incoming?
Idk INTS has some crazy weird movement rn i might dip out